Changes in Burnout, Resilience, and PTS Across Time Using Repeated Measures ANOVA. by Rachel G. Baskin (22127334)

Subjects:

Analysis of the Path Effects of Burnout and Resilience on  Stress Specific to COVID-19 and PTS via Multiple Linear Regressions, with Standardized Beta Coefficients (Standard Error)... by Rachel G. Baskin (22127334)

Subjects:

Tests of Direct Effects of Burnout and Resilience on Stress Specific to COVID-19 and PTS at T3. by Rachel G. Baskin (22127334)

Subjects:

Multiple Linear Regression of the Effects of Work Resources and Prior Traumatic Events on Stress Specific to COVID-19. by Rachel G. Baskin (22127334)

Subjects:

Tests of the Indirect Effects Using Bootstrapping. by Rachel G. Baskin (22127334)

Subjects:

Participant demographics, Measured at T1 (May 2020- June 2021). by Rachel G. Baskin (22127334)

Subjects:

Proposed path model of the effects of prior trauma, adequate work resources, burnout and resilience on stress specific to COVID-19 and PTS. by Rachel G. Baskin (22127334)

Subjects:

RM-ANOVA Post hoc Testing for PTS Across Time. by Rachel G. Baskin (22127334)

Subjects:

Variables, the Time Points Collected, and the Number of Nurses Who Responded. by Rachel G. Baskin (22127334)

Subjects:

Descriptive Statistics of Stress Specific to COVID-19, Burnout, Resilience, PTS, and Adequate Work Resources. by Rachel G. Baskin (22127334)

Subjects:

Anion-Assisted Glycosylation of Galactose: A Computational Study by Kerli Tali (22769704)

Subjects:

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Socio-demographic characteristics of key informants (n = 21). by Beshir Bedru Nasir (8218863)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects: